Time to give up on biosimilars in the United States?
An article was recently published in the Wall Street Journal by a visiting scientist at MIT’s Sloan School of Management, Mark Trusheim, and a physician and director of Drug Pricing Lab at Memorial Sloan Kettering Cancer Center, Peter Bach. Bach…